Table 1.
Baseline Clinical and Laboratory Characteristics of the Study Population
| Characteristic | Total Population (n = 45) | CHD (n = 27) | No CHD (n =18) | P |
|---|---|---|---|---|
| Female gender, n (%) | 13 (29) | 6 (22) | 7 (39) | 0.38 |
| Age (yr), mean (SD) | 65 (10) | 64 (10) | 67 (10) | 0.30 |
| Stroke, n (%) | 1 (2) | 1 (4) | 0 (0) | — |
| Smoker, n (%) | 9 (20) | 7 (26) | 2 (11) | 0.49a |
| Former smoker, n (%) | 15 (33) | 8 (30) | 7 (39) | 0.49a |
| History of arterial hypertension, n (%) | 35 (78) | 22 (82) | 13 (72) | 0.29a |
| Hyperlipidemia, n (%) | 30 (67) | 19 (70) | 11 (61) | 0.24a |
| HbA1c (%), mean (SD) | 5.5 (0.4) | 5.6 (0.5) | 5.4 (0.2) | 0.013 |
| Total cholesterol (mg/dL), mean (SD) | 151 (46) | 151 (53) | 151 (35) | 0.98 |
| Creatinine (mg/dL), mean (SD) | 1.0 (0.2) | 1.0 (0.2) | 0.9 (0.2) | 0.19 |
| Lipoprotein(a) (nmol/L), mean (minimum–maximum) | 31.5 (7–339) | 25 (7–339) | 38 (7–218) | 0.85b |
a
Fisher's exact test.
b
Wilcoxon rank-sum test.